Business Wire

NRI Secure Launches Japan's First "Blockchain Assessment" Service

Share

NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Overview of the "Blockchain Assessment" Service (Graphic: Business Wire)

As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or even to actual damage*4 by causing services to behave differently than originally intended.

In response to these issues, NRI Secure has systematized its accumulated knowledge and insights in the form of the “Blockchain Assessment” service. As its first step, NRI Secure will be launching the security assessment service for smart contracts. The service performs assessment from the dual perspectives of static analysis, which carefully analyzes a program, and dynamic analysis, which involves simulating a real attack, in order to identify vulnerabilities.

More assessment menus for other constituent elements of the blockchain will be added in the future. (2 to 4 in the overview diagram). This service is only available in English and Japanese.

NRI Secure continues to provide a variety of products and services for supporting companies and organizations in their information security measures, and to contribute to the creation of a safe information system environment and society on a global scale.

 
*1   First-ever in Japan: This is the first security assessment service designed specifically for the blockchain to be provided by a medium- or large-scale security vendor in Japan (according to NRI Secure research).
*2 Blockchain technology: A technology which achieves a distributed consensus among its participants and makes it possible to manage audit trails for all transactions, without the intervention of a trusted third party. Given such features as its ability to make falsifying data extremely difficult, its near-zero downtime, its lack of a centralized manager, and its high transaction performance, the blockchain has been lauded for being inexpensive to develop and for its potentially broad application as a way for companies to exchange information. These features have led to expectations that the blockchain can be used not only for cryptocurrencies such as Bitcoin, but as a circulation platform for transactions involving various asset types. Furthermore, this technology is also gaining notice for its potential use in the recording and storage of more common types of contracts, as well as in automatic contract execution.
*3 Smart contracts: This refers to contracts which are programmed and can be automatically executed. A smart contract is arranged with the execution conditions and contractual terms prescribed in advance, such that the contract is automatically executed when a transaction occurs matching said conditions. Smart contracts are being considered for use in securities settlements, real property transactions, the sharing economy, and numerous other fields that involve contracts.
*4 Actual damage: “The DAO Incident” occurred on June 17, 2016. Funds (virtual currency) held by “The DAO,” a virtual corporation established by a Germany-based venture capital company, were transmitted to a cyber-attacker who had exploited vulnerabilities in The DAO’s smart contract programming code.
*5 DApps: This abbreviation stands for Decentralized Applications, and refers to applications that are decentralized and distributed. They are said to enable the use of highly-reliably, low-cost applications via blockchain technology, without the need for a centralized system manager.
 

About NRI Secure

NRI SecureTechnologies is a subsidiary of Nomura Research Institute (NRI) specializing in Cybersecurity, and a leading global provider of next-generation managed security services and security consulting. Established in 2000, NRI SecureTechnologies is focused on delivering high-value security outcomes for our clients with the precision and efficiency that define Japanese quality.
For more details, visit us at http://www.nri-secure.com

Reference

“Blockchain Assessment” Service

  • Supported platforms: Ethereum, Hyperledger Fabric
    *Additional platforms will be supported at a later time.
  • Supported languages: Solidity, Go, Java
    *Please contact us regarding any other languages.
  • Price: Estimates will be provided on an individual basis.
  • For more details on the “Blockchain Assessment” Service, please contact: info@nri-secure.co.jp.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Inquiries
NRI SecureTechnologies, Ltd.
Hitomi Nemoto, +81-3-6706-0622
Public Relations
info@nri-secure.co.jp
Service Inquiries
NRI SecureTechnologies, Ltd.
Teruhiro Tagomori / Takenori Kiuchi, +81-3-6706-0622
Cyber Security Services Department II
info@nri-secure.co.jp

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

HiddenA line styled icon from Orion Icon Library.Eye